Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A 403 Forbidden error now displays on the study details page, replacing the content that previously showed trial information. This prevents users from viewing enrollment details, eligibility criteria, and contact information.
    Difference
    0.5%
    Check dated 2026-09-26T17:04:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page renders a 403 Forbidden error with the site chrome visible, replacing the expected study details and related navigation. This indicates an access issue rather than an update to study content.
    Difference
    17%
    Check dated 2026-09-19T18:34:59.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a small update to page metadata/UI without changes to the trial details.
    Difference
    0.0%
    Check dated 2026-08-29T19:26:39.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, reflecting a minor adjustment to the study record metadata.
    Difference
    0.0%
    Check dated 2026-08-08T18:44:59.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4 to reflect a new version of the page.
    Difference
    0.0%
    Check dated 2026-07-25T10:29:11.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor update to the page's content or formatting since the last version.
    Difference
    0.0%
    Check dated 2026-07-03T22:36:44.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.